XML 11 R1.htm IDEA: XBRL DOCUMENT v3.25.2
Cover - shares
 6 Months Ended
Jun. 30, 2025
Aug. 14, 2025
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Jun. 30, 2025  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2025  
Current Fiscal Year End Date --12-31  
Entity File Number 001-41952  
Entity Registrant Name Telomir Pharmaceuticals, Inc.  
Entity Central Index Key 0001971532  
Entity Tax Identification Number 87-2606031  
Entity Incorporation, State or Country Code FL  
Entity Address, Address Line One 100 SE 2nd St  
Entity Address, Address Line Two Suite 200 #1009  
Entity Address, City or Town Miami  
Entity Address, State or Province FL  
Entity Address, Postal Zip Code 33131  
City Area Code (786)  
Local Phone Number 396-6723  
Title of 12(b) Security Common Stock, no par value  
Trading Symbol TELO  
Security Exchange Name NASDAQ  
Entity Current Reporting Status No  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   32,280,970